Franklin Biotechnology Discovery A - FBDIX
8635 views
Rate Now: 1 2 3 4

average rating: 0.00 / 0 ratings
DESCRIPTION:

Date updated:12-11-2007

This fund has a Morningstar rating of 2 stars and is run by Evan McCulloch. McCulloch is a portfolio manager with Franklin Advisers, his employer since 1992. He first joined the company as a management trainee. He holds the Chartered Financial Analyst designation. Franklin Biotechnology Discovery Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The Fund invests a substantial portion of its assets in equity securities of smaller capitalization companies.


Current Returns:

1-Year: -0.23%
3-Year: 5.30%
5-Year: 11.74%

As of 9/30/07

symbol name last price % change open
  • +
  • GILD
    Gilead Sciences
  • $43.09
  • +0.75%
  • $42.40

No Analysis added

People owning GILD also tend to own: ACLALXNBMRNCELGCVHCVSESRX

TheStreet.com Rating: B What is this?

  • +
  • CELG
    Celgene Corporati
  • $44.28
  • +3.94%
  • $42.61

No Analysis added

People owning CELG also tend to own: ACLALXNBMRNCVHCVSESRXGENZ

TheStreet.com Rating: C What is this?

  • +
  • DNA
    N/a
  • $80.43
  • 0.00
  • $80.43

No Analysis added

People owning DNA also tend to own: ABTAMGNBDXBMYCAHFRXGENZ

TheStreet.com Rating: B What is this?

  • +
  • AMGN
    Amgen Inc.
  • $50.73
  • +1.26%
  • $50.40

No Analysis added

People owning AMGN also tend to own: AAPLGESGPCECEMRVLOMRIANF

TheStreet.com Rating: B What is this?

  • +
  • GENZ
    Genzyme Corporati
  • $60.94
  • +2.58%
  • $59.73

No Analysis added

People owning GENZ also tend to own: LRCXWRLDAMGNDNAAMZNBLUDHPQ

TheStreet.com Rating: C What is this?

  • +
  • PDLI
    Pdl Biopharma
  • $7.01
  • 0.00%
  • $7.00

No Analysis added

People owning PDLI also tend to own: AMDEXELTASRAFFXBVFAIBBHI

TheStreet.com Rating: C What is this?

  • +
  • VRTX
    Vertex Pharmaceut
  • $30.83
  • +2.63%
  • $29.14

No Analysis added

People owning VRTX also tend to own: EXPEIACIMCDXECHGSIIDIXITMN

TheStreet.com Rating: D- What is this?

  • +
  • MYGN
    Myriad Genetics
  • $37.70
  • +2.20%
  • $36.67

No Analysis added

People owning MYGN also tend to own: ABTACLAETALXNBAXBDXBIIB

TheStreet.com Rating: B What is this?

previous next

Portfolio not tracked!

  • No Blogs Found

Comments not available

ADD YOUR COMMENTS:

Four Must-See Charts: Stem Cell ...

By Stockpickr Staff Posted on July 2, 2009 Developments in the stem cell world are starting to get very interesting. On Tuesday, General Electric (GE) signed an exc...

07.02.09 | 15:19 PM
Stockpickr's Picks of the Day: J...

By Rebecca Corvino Posted on July 2, 2009 Every day, Stockpickr members are creating and sharing stock ideas with each other through various platforms. If you're not al...

07.02.09 | 13:43 PM
Cramer's Take on Headline Stocks...

By Rebecca Corvino Posted at 12:30 p.m. EDT on July 2, 2009 Making Thursday's headlines and sending stocks lower were reports that June saw the loss of 467,000 more job...

07.02.09 | 12:31 PM
Dividend Stocks for the Week

By Stockpickr Staff Posted on July 2, 2009 Some investors assume that at this time of year, it's the summer doldrums for the stock market. After all, as the saying goe...

07.02.09 | 11:02 AM
more articles
The Presidential/Political Thread
01.02.08 | 08:05 AM From author Dave Cox
General market Technical Analysi...
11.14.07 | 22:55 PM From author ZA
Will black social ills take a ba...
11.22.08 | 18:53 PM From author Valerie Vecchio
Wealth distribution by race and ...
11.23.08 | 18:44 PM From author Valerie Vecchio
more forums
Q. Goldman ... http://zerohedge....
07.05.09 | 23:05 PM Asked by CallaLilly

A. fascinating story. I had read last week
of goldman pullig out of some reporting
making it more secretive. I guess we
are learning why

today 's lists
TSC Ratings Downgrades

These stocks were downgraded by TheStreet.com Ratings on July 1, 2009. Check out the full article here.... more

Analyst Downgrades

Analyst Downgrades for July 1, 2009. Read more here. more

52-Week Lows

Here is a list of some of the biggest stocks that hit 52-week lows as of July 1, 2009. more